Market News

Analysts See $-0.18 EPS for Evogene Ltd. (EVGN); Axt (AXTI) Shorts Raised By 4.44%

Axt Incorporated (NASDAQ:AXTI) had an increase of 4.44% in short interest. AXTI’s SI was 1.56 million shares in February as released by FINRA. Its up 4.44% from 1.50 million shares previously. With 647,700 avg volume, 2 days are for Axt Incorporated (NASDAQ:AXTI)’s short sellers to cover AXTI’s short positions. The SI to Axt Incorporated’s float is 4.98%. The stock decreased 1.59% or $0.125 during the last trading session, reaching $7.725. About 31,588 shares traded. AXT, Inc. (NASDAQ:AXTI) has risen 115.17% since February 8, 2017 and is uptrending. It has outperformed by 98.47% the S&P500.

Analysts expect Evogene Ltd. (NASDAQ:EVGN) to report $-0.18 EPS on February, 26.They anticipate $0.08 EPS change or 30.77% from last quarter’s $-0.26 EPS. After having $-0.20 EPS previously, Evogene Ltd.’s analysts see -10.00% EPS growth. The stock increased 3.57% or $0.12 during the last trading session, reaching $3.48. About 640 shares traded. Evogene Ltd. (NASDAQ:EVGN) has declined 23.47% since February 8, 2017 and is downtrending. It has underperformed by 40.17% the S&P500.

Investors sentiment decreased to 1.21 in Q3 2017. Its down 0.28, from 1.49 in 2017Q2. It worsened, as 14 investors sold AXT, Inc. shares while 25 reduced holdings. 20 funds opened positions while 27 raised stakes. 23.45 million shares or 1.37% less from 23.77 million shares in 2017Q2 were reported. Panagora Asset Mgmt reported 18,406 shares. Manufacturers Life Insurance The owns 29,871 shares or 0% of their US portfolio. Us Fincl Bank De reported 100 shares. Ariel Investments Limited Liability Com holds 0.04% or 390,513 shares. Blackrock, New York-based fund reported 2.55M shares. Oberweis Asset Mngmt reported 0.84% in AXT, Inc. (NASDAQ:AXTI). Princeton Management owns 265,891 shares. Commercial Bank Of America Corp De stated it has 0% in AXT, Inc. (NASDAQ:AXTI). Deutsche Bancshares Ag invested 0% of its portfolio in AXT, Inc. (NASDAQ:AXTI). Goldman Sachs Group Inc reported 0% stake. Ameritas Invest Ptnrs accumulated 3,267 shares. First Manhattan reported 0% stake. Texas-based Dimensional Fund Advsr Ltd Partnership has invested 0.01% in AXT, Inc. (NASDAQ:AXTI). Gru One Trading L P invested 0% in AXT, Inc. (NASDAQ:AXTI). Amer Group holds 0% in AXT, Inc. (NASDAQ:AXTI) or 24,952 shares.

AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates. The company has market cap of $297.94 million. The firm makes its semiconductor substrates using its proprietary vertical gradient freeze technology. It has a 31.15 P/E ratio. It offers semi-insulating gallium with arsenic substrates, which are used for applications in power amplifiers for wireless devices, and transistors and solar cells for drones.

Among 7 analysts covering AXT Inc (NASDAQ:AXTI), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. AXT Inc had 14 analyst reports since December 9, 2015 according to SRatingsIntel. Northland Capital maintained it with “Buy” rating and $11.0 target in Thursday, October 26 report. The firm has “Buy” rating given on Wednesday, December 9 by B. Riley & Co. Needham maintained AXT, Inc. (NASDAQ:AXTI) rating on Thursday, October 26. Needham has “Buy” rating and $11.0 target. The company was upgraded on Tuesday, May 3 by Craig Hallum. The stock has “Buy” rating by Needham on Thursday, October 27. B. Riley & Co downgraded the stock to “Neutral” rating in Friday, March 17 report. On Thursday, October 26 the stock rating was maintained by B. Riley & Co with “Neutral”. The stock has “Buy” rating by Dougherty & Company on Monday, February 13. The firm earned “Buy” rating on Friday, June 16 by Dougherty. Needham maintained AXT, Inc. (NASDAQ:AXTI) rating on Thursday, February 23. Needham has “Buy” rating and $8.50 target.

Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States and Germany. The company has market cap of $88.01 million. It operates through two divisions, Evogene and Evofuel. It currently has negative earnings. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

Leave a Reply

Your email address will not be published. Required fields are marked *